Message #19 From:
NewsBot Date: March 19, 2007 04:00:00 AM
CMED News China Medical Technologies to Participate in the 10th Credit Suisse Asian Investment Conference 2007
BEIJING--(BUSINESS WIRE)--China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic systems and high intensity focused ultrasound products, today announced that it will participate in the 10th Credit Suisse Asian Investment Conference 2007.
Location: Hong KongDate: March 27-30, 2007
China Medical’s management team will meet with securities analysts and institutional portfolio managers in individual meetings and will discuss the Company’s strategy, operations and growth opportunities, as well as its published results to date.
Please contact Credit Suisse for more information about the conference.
About China Medical Technologies
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostics products using enhanced chemiluminescence (ECLIA) and Fluorescent in situ Hybridization (FISH) technology, to detect and monitor various diseases and disorders, and products using high intensity focused ultrasound for the treatment of solid cancers and benign tumors. For more information, please visit www.chinameditech.com.
